Due to the inherent heterogeneity and dynamic expression of EpCAM and the degradation of cytokeratin during the transformation of epithelial cells into mesenchymal cells, the detection of circulating tumor cells in hepatocellular carcinoma with conventional methods is significantly limited, leading to false-negative detection of such CTCs. Here, EPCAM is linked to hepatocellular carcinoma.